RESEARCH DATABASE

InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Effects of the SGLT2 inhibitor dapagliflozin on fluid distribution

Nephrology
Author
Ohara et al.
Used Parameters : TBW, ICW, ECW, ECW/TBW

Publication Year : 2018

Country : Japan

Journal : Nephrology


Full text